A study to assess drug absorption of fixed dose combinations of budesonide, glycopyrronium, and formoterol

Trial Identifier: D5985C00001
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT04600505
Start Date: October 2020
Primary Completion Date: May 2021
Study Completion Date: May 2021
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations